Premature Ejaculation Treatment Market- Insights
Ejaculation means discharging of semen from the body. Premature ejaculation (PE) also known as rapid ejaculation, premature climax or early ejaculation is a condition in which the ejaculation happens earlier than a man or his partner would like during a sexual intercourse. The main sign of PE is incapability to delay ejaculation for more than one minute after penetration. Mainly PE can be classified in two types, namely lifelong (primary) PE and acquired (secondary) PE.
Lifelong (primary) PE is a condition, which affects a male lifelong, nearly from the beginning of his first sexual encounter. Acquired (secondary) PE is a condition in which a male who has a normal sex life starts suffering from PE. The actual cause of PE is not known, however, it can caused due to some psychological and biological factors such as early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Frequent launches and approvals of novel premature ejaculation treatment products is expected to drive growth of the market
Key players in the market are focusing on launching new products, which in turn is expected to aid in growth of the market. For instance, in 2012, Absorption Pharmaceuticals, LLC launched its Promescent, an over-the-counter lidocaine-based spray, indicated for premature ejaculation. Furthermore, in 2013, Absorption Pharmaceuticals, LLC received patent for its Promescent, for premature ejaculation (PE) from the U.S. Patent and Trademark Office. The launches of novel drugs, which are indicated for the treatment of premature ejaculation is expected to fuel growth of the global premature ejaculation treatment market in the near future.
The global premature ejaculation treatment market size was valued at US$ 1.5 Bn in 2017, and is expected to witness a CAGR of 8.7% over the forecast period (2018 – 2026).
Figure 1. Global Premature Ejaculation Treatment Market Share (%), By Region, 2022
Source: Coherent Market Insights Analysis (2018)
Increasing strategic collaborations for development of new diagnostic tools is expected to propel the market growth
Key players in the market are involved in strategic collaborations for the development of premature ejaculation treatment drugs. For instance, in 2012, Ampio Pharmaceuticals, Inc. entered in a strategic agreement with Ethypharm S.A. for the manufacturing of Zertane, Ampio's drug indicated for the treatment of premature ejaculation. In 2013, Absorption Pharmaceuticals LLC entered into a strategic collaboration with Kaiser Permanente for initiating clinical trial to evaluate the efficacy of Promescent lidocaine spray for men with premature ejaculation (PE). Such strategic collaborations by key players for the development, manufacturing, and evaluation of novel drugs is expected to fuel the global premature ejaculation treatment market growth.
Figure 2. North America Premature Ejaculation Treatment Market Share (%), By Country, 2022
Source: Coherent Market Insights Analysis (2018)
Furthermore, key players are involved in raising funds for the development of drugs and are focused on expanding its sales network, in order to increase their sales. For instance, in 2013, Absorption Pharmaceuticals LLC, a manufacturer of Promescent spray indicated for treatment of premature ejaculation, expanded its international sales team. In 2014, Vyrix Pharmaceuticals, Inc., a subsidiary of Aytu BioScience, raised around US$ 28.75 million. The company financed development of tramadol hydrochloride (Zertane), indicated for the treatment of premature ejaculation from these funds.
Increasing prevalence of premature ejaculation is expected to increase demand for premature ejaculation drugs. For instance, according to the data published by European Association of Urology in 2017, the prevalence rate of premature ejaculation in the U.S. was estimated to be 30% (18-29 years), 32% (30-39 years), 28% (40-49 years), and 55% (50-59 years). According to the same source, the prevalence rate of four sub-types of erectile dysfunction was were 2.3% (lifelong PE), 3.9% (acquired PE), 8.5% (natural variable PE), and 5.1% (premature-like ejaculatory dysfunction). Such high prevalence of premature ejaculation is expected to lead to high demand for its treatment drugs and drive premature ejaculation treatment market growth.
Launch of alternative treatment methods for premature ejaculation is expected to be a major factor, which can restrain the market growth. For instance, in May 2018, InnovaDerma PLC launched a device, Prolong. Prolong is a FDA approved device used in the treatment of premature ejaculation. Launches of such devices is expected to restrain growth of the global premature ejaculation treatment market
Key players operating in the premature ejaculation treatment market include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.